Corporate Governance

The Board is committed to high standards of corporate governance

The Board

The Board consists of a Non-Executive Chairman and three Executive Directors.
There is a clear division of responsibility between the Chairman who leads the Board and the Chief Executive who is responsible for the business operation. The Non-Executive Chairman is considered to be independent of the management and brings his objective judgement to the Board’s strategic plans, business activities and decisions.

Board Committees

The Board has established two committees, Remuneration and Audit Committees.

The Remuneration Committee is chaired by Non-Executive Chairman John French.
The Audit Committee is chaired by Non-Executive Chairman John French.

Internal Control

The Board is responsible for the Company’s system of internal control and for reviewing its effectiveness.
The Board reviews the effectiveness of the system of internal control on a regular basis and at least annually. The effectiveness of this process is reviewed by the Audit Committee.

Relations with Shareholders

The Company has a programme of communication with shareholders that includes regular meetings with, and presentations to, institutional shareholders, fund managers and analysts. Share price information, copies of annual reports, press releases and analyst’s research notes are available on this website (see Investor Centre). The Company also sends out regular email communications to its shareholders to keep them up to date on the Company’s news. The Company welcomes shareholders who attend the Annual General Meeting (AGM) as it provides an opportunity for shareholders to meet and raise questions with the Board.

 

Sutherland®

Sutherland Health Group Plc